Correlation Between Inozyme Pharma and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Hepion Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Hepion Pharmaceuticals
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Inozyme and Hepion is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Hepion Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Hepion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.33 times less risky than Hepion Pharmaceuticals. The stock trades about -0.23 of its potential returns per unit of risk. The Hepion Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 73.00 in Hepion Pharmaceuticals on September 12, 2024 and sell it today you would lose (10.00) from holding Hepion Pharmaceuticals or give up 13.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inozyme Pharma vs. Hepion Pharmaceuticals
Performance |
Timeline |
Inozyme Pharma |
Hepion Pharmaceuticals |
Inozyme Pharma and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Hepion Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.Inozyme Pharma vs. Equillium | Inozyme Pharma vs. DiaMedica Therapeutics | Inozyme Pharma vs. Valneva SE ADR | Inozyme Pharma vs. Vivani Medical |
Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |